JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Amalgamation/Merger
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals will acquire 7.44 crore equity shares (46.39% of expanded share capital) from current promoter Tau Investment Holdings for cash, taking control of JB Chemicals & Pharmaceuticals. Because Torrent is crossing the 25% voting rights threshold and gaining control, a mandatory open offer to public shareholders has been triggered. Separately, the boards have approved a scheme of amalgamation where JB Chemicals will merge into Torrent Pharmaceuticals at a swap ratio of 51 Torrent shares (face value Rs 5) for every 100 JB Chemicals shares (face value Rs 1). The merger is subject to NCLT, Competition Commission of India, and shareholder/creditor approvals. Post-merger, JB Chemicals will cease to exist as a separate listed entity, and public shareholders will receive Torrent shares instead.
JB Chemicals shareholders will end up holding shares in the larger Torrent Pharmaceuticals after the merger, so the stock will likely trade with a strong correlation to the swap ratio and Torrent's share price until the scheme becomes effective. The mandatory open offer gives public shareholders an exit opportunity at a price to be announced by Torrent. Expect sharp price movement in JB Chemicals stock in the near term as the market prices in the deal.